Our mission is to improve the lives of patients living with cancer and chronic diseases across the world. We recognize the importance of understanding the challenges faced by patients in order to provide the support they need.
Helsinn’s Early Access Programs (EAP) allow patients with life threatening conditions access to cancer therapeutic products they would not otherwise have had access to.
Helsinn is committed to funding programs that communicate relevant scientific information to the medical community with the overall aim of improving patient care.
Helsinn Healthcare SA. All rights reserved. Helsinn Group 2025 ©
Please click ‘Continue to external site’ if you want to continue.
